Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection

Gary P. Wang*, Norah Terrault, Jacqueline D. Reeves, Lin Liu, Eric Li, Lisa Zhao, Joseph K. Lim, Giuseppe Morelli, Alexander Kuo, Josh Levitsky, Kenneth E. Sherman, Lynn M. Frazier, Ananthakrishnan Ramani, Joy Peter, Lucy Akuskevich, Michael W. Fried, David R. Nelson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint Dive into the research topics of 'Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection'. Together they form a unique fingerprint.

Medicine & Life Sciences